targeting t-cell malignancies with crispr/cas9 gene edited universal car-t
Published 4 years ago • 739 plays • Length 3:57Download video MP4
Download video MP3
Similar videos
-
2:21
crispr-cas9 genome editing technology in the development of t cell therapies
-
3:39
car t-cells and crispr: the future of aml treatment
-
1:44
developing autologous t-cell therapies with crispr-cas technology
-
1:55
crispr/cas9 edited t-cells in mm and sarcoma
-
1:38
genome editing tools in t cell-based immunotherapies
-
0:51
developing universal car-t therapies for t-all
-
11:18
car-t cells: engineered cancer killers
-
15:22
improving car-t cell therapies (immunotherapy documentary part iii)
-
4:17
crispr gene editing will transform cancer treatment
-
1:55
developing the next generation of car-t cells
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
39:56
crispr/cas9-based genome editing for autologous car-t cell production
-
4:27
car t-cell therapy horizon scan
-
3:17
tcxpress™ vs car-t therapy & targeting leukemia with tcr t-cells
-
1:42
challenges associated with car-t cell production
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:25
bleeding and thrombotic complications in car t-cell therapy for b-cell malignancies
-
2:02
using crispr and non-viral dna in t cell engineering
-
1:02
the use of car-t cell products in a real-world setting
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
1:38
genetically modified t-cell therapy in multicenter trials